{
  "Study_ID": "Das2007",
  "First_Author": "Das K",
  "Year": "2007",
  "Country": "India",
  "Study_Design": "Randomized controlled study",
  "Risk_of_Bias": "Moderate - randomized but unclear allocation concealment method",
  "Diagnostic_Criteria": "Two or more well-defined round hypodense lesions with ring enhancement on CT, at least one in vesicular stage, positive ELISA for cysticercosis antibodies",
  "Total_Sample_Size": "300",
  "Treatment_Group_N": "150",
  "Control_Group_N": "150",
  "Age_Mean_SD": "Group A: 28 ± 2 years, Group B: 30 ± 2 years",
  "Male_Percentage": "59.3 (178/300)",
  "Female_Percentage": "40.7 (122/300)",
  "Other_Demographics": "80% agricultural workers, literacy rate 69.22%",
  "Headache_Percentage": "Reported but percentage not specified",
  "Focal_Seizures_Percentage": "Group A: 42.7% (64/150), Group B: 46.7% (70/150)",
  "Other_Symptoms": "Encephalopathy (headache/vomiting/altered sensorium)",
  "Treatment_Type": "Albendazole plus dexamethasone vs placebo",
  "Albendazole_Dose": "15 mg/kg/day",
  "Treatment_Duration_Days": "14",
  "Number_of_Cycles": "1",
  "Cycle_Interval_Days": "Not applicable",
  "Praziquantel_Dose": "Not used",
  "Corticosteroid_Type": "Dexamethasone 2mg every 8 hours",
  "Antiepileptic_Drug": "Phenytoin, carbamazepine, or valproate",
  "Follow_up_Duration_Months": "60",
  "Imaging_Schedule": "3 months after treatment, then every 6 months",
  "Complete_Resolution_Percentage": "At 5 years - Group A: 56.75%, Group B: 73%",
  "Partial_Resolution_Percentage": "At 5 years - Group A: 9.45%, Group B: 6.66%",
  "No_Change_Percentage": "At 5 years - 0% in both groups",
  "Seizure_Reduction_Percentage": "Control group had better seizure outcomes; treatment group had higher recurrence (p=0.05)",
  "Elevated_Liver_Enzymes_Percentage": "Not reported",
  "Other_AE": "Treatment group: 2 deaths from intractable seizures and encephalopathy, increased hospital readmissions, higher calcification rate (33.78% vs 22.66%)",
  "Comments": "Albendazole treatment showed no benefit over antiepileptic drugs alone, and was associated with increased adverse events and higher calcification rates. Control group showed better lesion resolution.",
  "last_modified": "2024-10-31T14:29:35.781349"
}